Jane Street
AZN icon

Jane Street’s AstraZeneca AZN Stock Holding History

Jane Street’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.6M Buy
134,750
+55,200
+69% +$10.6M ﹤0.01% 1536
2025
Q4 		$14.6M Buy
79,550
+29,700
+60% +$5.21M ﹤0.01% 1897
2025
Q3 		$7.65M Sell
49,850
-32,150
-39% -$4.87M ﹤0.01% 2786
2025
Q2 		$11.5M Buy
82,000
+68,750
+519% +$9.64M ﹤0.01% 1981
2025
Q1 		$1.95M Sell
13,250
-121,950
-90% -$17.6M ﹤0.01% 4391
2024
Q4 		$17.7M Buy
135,200
+28,950
+27% +$4.05M ﹤0.01% 1351
2024
Q3 		$16.6M Sell
106,250
-23,650
-18% -$3.82M ﹤0.01% 1399
2024
Q2 		$20.3M Sell
129,900
-330,250
-72% -$49.7M ﹤0.01% 1307
2024
Q1 		$62.4M Buy
460,150
+131,350
+40% +$17.4M 0.01% 530
2023
Q4 		$44.3M Sell
328,800
-135,950
-29% -$17.7M 0.01% 745
2023
Q3 		$62.9M Buy
464,750
+374,950
+418% +$51.2M 0.02% 472
2023
Q2 		$12.9M Sell
89,800
-52,400
-37% -$7.71M ﹤0.01% 1652
2023
Q1 		$19.7M Buy
142,200
+138,500
+3,743% +$18.6M 0.01% 1014
2022
Q4 		$502K Buy
3,700
+1,550
+72% +$194K ﹤0.01% 6142
2022
Q3 		$236K Sell
2,150
-52,800
-96% -$6.7M ﹤0.01% 7924
2022
Q2 		$7.26M Buy
54,950
+41,200
+300% +$5.41M ﹤0.01% 2147
2022
Q1 		$1.82M Sell
13,750
-50,086
-78% -$6.01M ﹤0.01% 4925
2021
Q4 		$7.44M Sell
63,836
-234,254
-79% -$27.6M ﹤0.01% 2266
2021
Q3 		$35.8M Buy
298,090
+107,040
+56% +$12.5M 0.01% 754
2021
Q2 		$22.9M Buy
191,050
+26,000
+16% +$2.85M 0.01% 978
2021
Q1 		$16.4M Sell
165,050
-81,850
-33% -$8.23M 0.01% 1137
2020
Q4 		$24.7M Buy
246,900
+116,750
+90% +$12.4M 0.01% 745
2020
Q3 		$14.3M Buy
130,150
+9,250
+8% +$1.03M 0.01% 964
2020
Q2 		$12.8M Buy
+120,900
New +$12.5M 0.01% 1024
2019
Q4 		– Sell
-2,250
Closed -$201K – 5032
2019
Q3 		$201K Buy
+2,250
New +$195K ﹤0.01% 4641
2019
Q2 		– Sell
-11,500
Closed -$930K – 5119
2019
Q1 		$930K Buy
11,500
+4,100
+55% +$323K ﹤0.01% 2899
2018
Q4 		$562K Buy
+7,400
New +$578K ﹤0.01% 3314
2018
Q3 		– Sell
-3,150
Closed -$221K – 5065
2018
Q2 		$221K Sell
3,150
-14,750
-82% -$1.06M ﹤0.01% 4459
2018
Q1 		$1.25M Buy
+17,900
New +$1.24M ﹤0.01% 2376
2017
Q2 		– Sell
-8,250
Closed -$514K – 4310
2017
Q1 		$514K Buy
8,250
+3,150
+62% +$183K ﹤0.01% 2846
2016
Q4 		$279K Sell
5,100
-38,750
-88% -$2.2M ﹤0.01% 3431
2016
Q3 		$2.88M Buy
43,850
+33,850
+339% +$2.21M 0.01% 912
2016
Q2 		$604K Buy
10,000
+2,450
+32% +$142K ﹤0.01% 2566
2016
Q1 		$425K Buy
+7,550
New +$454K ﹤0.01% 2784
2014
Q1 		– Sell
-48,700
Closed -$2.89M – 2668
2013
Q4 		$2.89M Buy
+48,700
New +$2.65M 0.04% 332
2013
Q3 		– Sell
-19,200
Closed -$908K – 2700
2013
Q2 		$908K Buy
+19,200
New +$978K 0.02% 980

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Jane Street's AZN Position: Q1 2026 in Review

Jane Street opened a new position in AstraZeneca (AZN) in Q1 2026: 844,701 shares worth $167M. The stake represents 0.02% of the portfolio and ranks #454 among its holdings. This is a return to the name: Jane Street previously reported a position in AZN as recently as Q3 2025.

Jane Street first reported a position in AZN in Q3 2013 and has held it in 44 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Jane Street held 844,701 shares of AstraZeneca worth $167M as of Q1 2026.
  • AstraZeneca was a new Jane Street position in Q1 2026.
  • AstraZeneca made up 0.02% of Jane Street's portfolio in Q1 2026, its #454 holding.
  • Jane Street first reported a position in AstraZeneca in Q3 2013 and has held it in 44 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.